Evaluation of mild cognitive impairment subtypes in Parkinson's disease

Brenna A Cholerton1, Cyrus P Zabetian, Jia Y Wan

  • 1Geriatric Research, Education, & Clinical Center, Seattle, Washington, USA; Department of Psychiatry & Behavioral Science, University of Washington School of Medicine, Seattle, Washington, USA.

Insights

Identifying distinct cognitive subtypes in Parkinson's disease with mild cognitive impairment (PD-MCI) is challenging. This study found that current criteria and statistical methods did not effectively separate PD-MCI patients into clear cognitive subtypes.

Area of Science:

  • Neurology
  • Cognitive Neuroscience
  • Neurodegenerative Diseases

Background:

  • Mild cognitive impairment in Parkinson's disease (PD-MCI) is prevalent and a risk factor for dementia.
  • Consistent identification of distinct PD-MCI cognitive subtypes remains elusive across studies.
  • Subtyping PD-MCI is crucial for predicting dementia conversion.

Purpose of the Study:

  • To investigate distinct cognitive subtypes within a PD-MCI cohort using established guidelines and statistical analysis.
  • To determine if current diagnostic criteria or factor analysis can reliably partition PD-MCI patients.

Main Methods:

  • Cognitive subtyping of 95 PD-MCI patients from the Pacific Northwest Udall Center Clinical Consortium.
  • Application of Movement Disorders Society Task Force diagnostic guidelines.
  • Principle components factor analysis on psychometric test scores.

Main Results:

  • Multiple-domain PD-MCI was diagnosed in 95% of participants.
  • Factor analysis identified seven factors with overlapping cognitive measures (e.g., verbal fluency, visuospatial skills).
  • These factors did not result in the clear separation of distinct cognitive subtypes.

Conclusions:

  • Current PD-MCI diagnostic criteria and statistical methods may not sufficiently differentiate cognitive subtypes.
  • Further research is needed to validate PD-MCI criteria and explore genetic or other risk factors.
  • Improved methods are required for characterizing cognitive heterogeneity in Parkinson's disease.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K